Data / Form D filings / Prosensa Holding N.V.
Prosensa Holding N.V.: Form D filing
Prosensa Holding N.V., a biotechnology company in Leiden, Netherlands, filed a Form D with the SEC in 2014. The latest, on December 8, 2014, reports $50.5 million sold of a $50.5 million offering to 1 investor.
Find out what Prosensa Holding N.V. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- J.H. OORTWEG 21, Leiden, Netherlands, 2333
- Phone
- 31 0 713322100
- Industry
- Biotechnology
- Entity type
- Other (Dutch Public Limited Liability Company)
- Incorporated in
- Netherlands
- Revenue range
- $5,000,001 - $25,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1574111
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 8, 2014 | New notice | $50,488,095 | $50,488,095 | $0 | 1 | Nov 26, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Luc Dochez | Executive Officer | |
| Giles Campion | Executive Officer | |
| Martijn Kleijwegt | Director | |
| Annalisa Jenkins | Director | |
| Daan Ellens | Director | |
| Berndt Modig | Executive Officer | |
| David Mott | Director | |
| Peter Goodfellow | Director | |
| Michael Wyzga | Director | |
| Hans Schikan | Executive Officer | |
| Georges Gemayel | Director |
Every Form D from the week of Dec 8, 2014 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Prosensa Holding N.V. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.